On April 4, 2012, the committee will discuss the data provided to support the safety and efficacy of levofloxacin for the treatment of pneumonic plague in humans. Johnson and Johnson Pharmaceutical Research and Development, LLC (on behalf of …
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Top 100 Pharmaceutical Enterprises and the Listed Company SZ.002020